User:lowendotoxinsapelizumab424305
Jump to navigation
Jump to search
Sapelizumab: A Novel Anti-CD23 Antibody for Clinical Potential
Sapelizumab, a unique specific antibody, represents the promising treatment strategy directed towards CD23, a cell molecule
https://tovetumabmonoclonalantib021070.mpeblog.com/78375413/text